Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| enVVeno Medical CorpNVNO · Entity 8104 | Chief Technology Officer | December 16, 2025 | December 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
enVVeno Medical Corp
Report date December 16, 2025 · Filed December 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-11-30 | Direct | 0 |
Reported balance
After 2025-12-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-16 · Other · Disposed 50,000 · Balance 0 F1: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2025 Filed Dec 18, 2025 17:49 UTC | enVVeno Medical Corp NVNO · Entity 8104 | OtherRestricted Stock Units · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028394 · ownership.xml · derivative · entry 1 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2031-11-30 F1 · derivative.exercise_date: The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 20:33 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 75,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001493152-24-051143 · ownership.xml · derivative · entry 1 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-12-18 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:00 UTC | enVVeno Medical Corp NVNO · Entity 8104 | Exercise / conversionStock Options · Derivative | 8,334 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001493152-24-010168 · ownership.xml · derivative · entry 3 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,666 Underlying: Common Stock · 8,334 shares Expires 2033-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:00 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 8,334 | $6.22 | $51,837.48 |
DisclosureSEC source: 0001493152-24-010168 · ownership.xml · nonDerivative · entry 2 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:00 UTC | enVVeno Medical Corp NVNO · Entity 8104 | Exercise / conversionCommon Stock | 8,334 | $3.59 | $29,919.06 |
DisclosureSEC source: 0001493152-24-010168 · ownership.xml · nonDerivative · entry 1 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 17:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 100,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001493152-23-044054 · ownership.xml · derivative · entry 1 Alavi Hamed · CIK 0001964081 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-12-05 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.